Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Winners of $2m ocean health prize revealed
ANB Sensors receiving cheque
Ocean acidification is damaging the health of shellfish, fisheries, coral reefs and other ecosystems.
UK team come second place, winning $250K

A team of UK scientists have won $250,000 in a global competition to develop accurate and affordable pH sensors to measure ocean chemistry.

The Wendy Schmidt Ocean XPRIZE is a $2 million award. It aims to tackle the growing problem of ocean acidification through the development of pH sensors.

Ocean acidification is already having a serious impact. Driven by rising CO2 emissions, it is damaging the health of shellfish, fisheries, coral reefs and other ecosystems.

Previously, the only available sensors were too expensive and imprecise to give sufficient knowledge of ocean chemistry.

First prize was awarded to US company Sunburst Sensors, who received $1.5 million for their sensor. Cambridge-based ANB Sensors came in second place for affordability, while Team Durafet, US, got second place for accuracy and also received $250,000.

A total of 24 teams from around the world battled it out for the top prize and after four months of testing, five teams were shortlisted to travel to Hawaii and carry out week-long trials of their sensors in May.

The work of the three teams brings us one step closer to tackling ocean acidification.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.